These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 8042329

  • 1. Role of surgical therapy in management of intractable ascites.
    Elcheroth J, Vons C, Franco D.
    World J Surg; 1994; 18(2):240-5. PubMed ID: 8042329
    [Abstract] [Full Text] [Related]

  • 2. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S, Labianca M, Borgonovo G, Smadja C, Grange D, Franco D.
    Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of intractable ascites in cirrhotic patients by portal shunt].
    Franco D.
    Gastroenterol Clin Biol; 1983 May; 7(5):533-9. PubMed ID: 6873567
    [Abstract] [Full Text] [Related]

  • 4. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S, Labianca M, Smadja C, Grange D, Franco D.
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [Abstract] [Full Text] [Related]

  • 5. [Combined use of peritoneo-atrial shunting and endoscopic sclerotherapy of esophageal varicose veins in treating liver cirrhosis with portal hypertension and resistant ascites].
    Vakhidov AV, Nazyrov FG, Strusskiĭ LP, Akilov KhA, Deviatov AV, Asabaev ASh.
    Klin Khir (1962); 1990 Oct; (9):3-5. PubMed ID: 2273775
    [Abstract] [Full Text] [Related]

  • 6. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.
    Smadja C, Franco D.
    Ann Surg; 1985 Apr; 201(4):488-93. PubMed ID: 3977450
    [Abstract] [Full Text] [Related]

  • 7. [Standardization of intensive therapy tactics for acute hepatic insufficiency in patients with liver cirrhosis after portosystem shunting].
    Ibadov RA, Babadzhanov AK, Irmatov SK, Gizatulina NR, Ibragimov SK, Ruziboev SA.
    Khirurgiia (Mosk); 2018 Apr; (8):61-67. PubMed ID: 30113595
    [Abstract] [Full Text] [Related]

  • 8. Long term results (greater than 5 years) in patients with peritoneovenous shunting for intractable ascites: liver function and cancer mortality.
    Franco D, Meakins JL, Wu A, Smadja C, Bonnet P, Gouffier E, Campillo B.
    HPB Surg; 1989 Oct; 1(3):185-91, discussion 191-4. PubMed ID: 2487384
    [Abstract] [Full Text] [Related]

  • 9. Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension.
    Hosokawa I, Adam R, Allard MA, Pittau G, Vibert E, Cherqui D, Sa Cunha A, Bismuth H, Miyazaki M, Castaing D.
    Br J Surg; 2017 Mar; 104(4):443-451. PubMed ID: 28079252
    [Abstract] [Full Text] [Related]

  • 10. [Role of surgical therapy in the treatment of refractory ascites].
    Pisani Ceretti A, Intra M, Borzio M, Santambrogio R, Opocher E, Ballarini C, Cordovana A, Motta R, Spina GP.
    Minerva Chir; 1997 Nov; 52(11):1339-48. PubMed ID: 9489332
    [Abstract] [Full Text] [Related]

  • 11. Treatment options for cirrhotic ascites.
    Wilkinson SP.
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):1-3. PubMed ID: 9565461
    [Abstract] [Full Text] [Related]

  • 12. Peritoneovenous shunting for intractable ascites.
    Gullstrand P, Alwmark A, Börjesson B, Joelsson B, Bengmark S.
    Scand J Gastroenterol; 1982 Nov; 17(8):1009-12. PubMed ID: 7167735
    [Abstract] [Full Text] [Related]

  • 13. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Nov; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 14. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
    Dissegna D, Sponza M, Falleti E, Fabris C, Vit A, Angeli P, Piano S, Cussigh A, Cmet S, Toniutto P.
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
    [Abstract] [Full Text] [Related]

  • 15. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J, Hoyos M, Viladomiu L, Rimola A, Morillas R.
    N Engl J Med; 1991 Sep 19; 325(12):829-35. PubMed ID: 1875966
    [Abstract] [Full Text] [Related]

  • 16. [Experience with the transjugular intrahepatic portocaval shunt].
    Dagenais M, Pomier Layrargues G, Dufresne MP, Roy A, Fenyves D, Lapointe R.
    Ann Chir; 1994 Sep 19; 48(8):671-8. PubMed ID: 7872613
    [Abstract] [Full Text] [Related]

  • 17. [Are surgical shunts still indicated?].
    Otto G.
    Chirurg; 1995 Jun 19; 66(6):566-73. PubMed ID: 7664585
    [Abstract] [Full Text] [Related]

  • 18. Selective distal splenorenal shunts for intractable variceal bleeding in pediatric portal hypertension.
    Evans S, Stovroff M, Heiss K, Ricketts R.
    J Pediatr Surg; 1995 Aug 19; 30(8):1115-8. PubMed ID: 7472961
    [Abstract] [Full Text] [Related]

  • 19. Use of Peritoneovenous Shunt for the Management of Refractory Ascites.
    Ayllón MD, Ciria R, Gómez-Luque I, Rodriguez-Perálvarez M, Padial A, Luque A, López-Cillero P, de la Mata M, Briceño J.
    Transplant Proc; 2019 Aug 19; 51(1):41-43. PubMed ID: 30655143
    [Abstract] [Full Text] [Related]

  • 20. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY, de la Roche E, Adham M, Ducerf C, Baulieux J.
    Ann Chir; 1998 Aug 19; 52(7):612-7. PubMed ID: 9805798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.